The native just-in-time compiler in Python 3.15 can speed up code by as much as 20% or more, although it’s still experimental ...

Netflix has announced a $72 billion deal to acquire Warner Bros. Discovery and its popular franchises. The merger would combine Netflix's 300 million subscribers with HBO Max's nearly 130 million ...

As Netflix strikes an $82.7 billion deal to acquire Warner Bros. — including its film and TV studios, plus HBO Max and HBO — many subscribers are wondering what that might ultimately mean for their ...

It's official: Netflix and Warner Bros. Discovery (WBD) have reached a definitive agreement allowing the streaming company to take possession of HBO, HBO Max, and the Warner Bros. film and television ...

Stranger Things returned in the early hours on Thanksgiving Eve for its fifth and final season, and it's safe to say we are stunned over what went down in those first four episodes. From that unreal ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Basic and Standard subscribers can stream HBO Max simultaneously on up to two devices, while Premium subscriptions up that limit to four devices. Otherwise, the main differences between plans is ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...